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Abstract
Compelling evidence broadens our understanding of tumors as highly heterogeneous populations derived from
one common progenitor. In this review we portray various stages of tumorigenesis, tumor progression, self-seeding
and metastasis in analogy to the superorganisms of insect societies to exemplify the highly complex architecture
of a neoplasm as a system of functional “castes.”
Accordingly, we propose a model in which clonal expansion and cumulative acquisition of genetic alterations
produce tumor compartments each equipped with distinct traits and thus distinct functions that cooperate to
establish clinically apparent tumors. This functional compartment model also suggests mechanisms for the self-
construction of tumor stem cell niches. Thus, thinking of a tumor as a superorganism will provide systemic insight
into its functional compartmentalization and may even have clinical implications.
Introduction
Cooperation and division of labor are thought to explain
many of the major transitions in evolution, in which
several simple units form a more complex group [1,2].
When conflict among their constituents is resolved or
sufficiently suppressed, such higher biological entities
achieve “organismality” at a higher level, i.e., they inter-
act with other such entities as “individuals” [3]. Major
transitions are the evolution from independently repli-
cating oligonucleotides into genomes, from prokaryotes
to eukaryotes, and from unicellular to multicellular
organisms. Another major transition, in which emergent
properties arising from cooperation and division of
labor are particularly obvious, is the origin of the social
insects from solitary organisms. The nests of social
insects - ants, termites, and honeybees - consist of hun-
dreds or thousands of individuals, which appear to inter-
act so smoothly and complementarily that the society as
whole has been referred to as a “superorganism,” in ana-
logy to the well-functioning organism of a multicellular
animal [4-10].
Superorganisms are societies composed of specialized
reproductives (queens and, in termites, kings) and non-
reproductive castes. Workers are fully dedicated to
support the royal reproductive caste in an altruistic fash-
ion - that is, they normally follow epigenetically pro-
grammed algorithms to fulfill their self-sacrificing
behavior of brood care, foraging, and colony defense
and in this way increase the reproductive success of the
queens (and kings). Rather than directly transmitting
copies of their own genes via their own offspring, work-
ers indirectly maximize their fitness via the offspring of
the reproductives, to whom they are usually closely
related [4,11-14].
Many superorganisms change their environment radi-
cally by constructing nests with microclimate control or
by connecting them with durable food sources by care-
fully maintained trails. Some species enrich their food by
growing fungi or herding sugar-producing insect sym-
bionts, and others pillage “slaves” from neighboring ant
nests during well-organized raids [5,6,15]. This all
requires closely controlled cooperation among indivi-
duals behaviorally or morphologically specialized for dif-
ferent tasks. Though the gene is the ultimate unit of
selection, the insect society as a whole has become target
of selection and may be envisaged as the “extended phe-
notype” of the reproductives’ genes [16]. Selection may
therefore optimize caste demography, patterns of division
of labor, and communication systems at the colony level.
A nascent colony has to overcome several barriers to
thrive and expand: young queens or fragments of
mature societies must locate an adequate nesting site,
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the workers have to find and collect nutrients, establish
home territories, defend the nest against enemies, and
care for the helpless young. The society as a whole may
respond flexibly to inductive stimuli either because indi-
viduals switch tasks in an opportunistic fashion or
because more individuals specialized for a particular
task are produced [17-20]. Division of labor in a super-
organism ultimately relies, at least in part, on self-orga-
nization with positive and negative feedback cycles and
usually lacks control by a still higher-level system
[17,19,21].
In analogy, there has been great progress in the
understanding of solid neoplasms as highly heteroge-
neous organ-like tissues with a hierarchical cellular
organization [22]. Although all cells within a tumor are
most likely derived from one common ancestor [23],
they differ substantially in shape and function rather
than being clonal monocultures [24,25]. Recent data
suggest that a solid tumor contains quiescent cells [26]
that maintain a stable functioning tumor despite exter-
nal perturbations by therapy [27]. Those cells are likely
not mere hibernating bystanders but rather differen-
tiated cells that actively promote proliferation of their
clonemates in accomplishing growth-fostering functions.
These may include angiogenesis, immunoediting and
construction of an advantageous microenvironment to
shelter the tumor stem cells (TSCs) [28-30]. The func-
tional variety of these diversely differentiated tumor
cells resembles phenomena seen in superorganisms of
social insects.
As indicated above, cooperation among biological
entities and subsequent specialization of individuals for
specific tasks (division of labor) are general, wide-ran-
ging, and efficient phenomena in evolution [1]. In ana-
logy to these major transitions, and in particular in
analogy to the superorganism, the principle of division
of labor may also apply in the hierarchical self-construc-
tion of neoplasias as complex organ-like tissues. In the
following chapters we will propose a model for the self-
construction of TSC niches and explain how the think-
ing of solid tumors as superorganisms may have rele-
vance to the development of novel therapeutic
approaches against cancer.
Clonal and functional relationships of solid
neoplasms and superorganisms
It is a widespread consensus that most human tumors
are monoclonal growths descending from single pro-
genitor cells [31,32] that - through several rounds of
mutations and selection - overcome the constraints
imposed by intercellular competition [33,34]. Although
this linear cancer progression model is supported by
sound and recent evidence, it is still unclear how a nas-
cent tumor might manage to prepare the ground for
ongoing growth and how an already established tumor
might benefit from tumor heterogeneity (for review see
[35] and references therein), which is often observed in
specimens of large tumors [36]? Moreover, as most
tumors are quite advanced when detected comprising a
billion or more cells [32], late stages of tumor develop-
ment are far better understood than initial events. Yet,
these initial events are likely to be crucial for tumor
progression [24,37].
We therefore wonder what mechanisms govern the
self-assembly of a nascent tumor and what factors shape
its continuous development into a heterogeneous organ-
like structure?
We approach these questions from a sociobiological
perspective and model how principles of division of
labor as seen in social insects might operate within a
solid tumor to accomplish the needs of ongoing tumor
growth:
In our functional compartment model, solid neo-
plasms are hierarchically organized and like superorgan-
isms consist of different compartments or “castes” that
are epigenetically (and in the case of cancers possibly
also genetically) specialized for certain tasks. One com-
partment specializes in reproduction (TSCs), others in
foraging (angiogenesis) and still others contribute to the
tumor’s logistics and expansion (tissue invasion, vascular
access). Although only one compartment is de facto
reproductive, the cooperative (inter-)action of all com-
partments is essential for the fitness of the solid tumor
as a whole.
In social insects, the queen’s ovaries harbor the col-
ony-forming “stem cells” that produce rapidly proliferat-
ing oocytes - the stem cell’s closest progeny - which will
develop into offspring that support further upgrowth of
the colony. Workers, the “somatic units” of a superor-
ganism, perceive and interact with the environment to
ensure nutrient supply and to shelter the queen and
thus the stem cells. Defensive castes destroy the envir-
onment’s “immune system” and protect the colony from
external attacks. Specific workers are first to invade and
explore uncertain terrain and recruit specialized workers
(foragers) that modify the microenvironment to access
the colony supporting nutrients [5,6].
In analogy, the TSC concept, which was first indicated
in the late 19th century [38], states that only a few scat-
tered cells within a neoplasm can give rise to progeny
[25] through infrequent asymmetric cell division [39].
Although TSC have not yet been identified in some
tumor entities, there is compelling evidence that many can-
cers including breast, colon and brain cancer follow a hier-
archical TSC model [25,40-42]. In these tumors the rapidly
proliferating progeny of the TSCs gradually casts off stem
cell traits like self-renewal and multi-potency while simul-
taneously acquiring defined functional properties through
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(incomplete) differentiation [25]. This most likely happens
due to activation and maintenance of distinct gene expres-
sion signatures upon stimuli received from other tumor
cells and/or the microenvironment [25,43]. In the TSC’s
vicinity part of this non-tumorigenic progeny forms a shel-
ter often referred to as the “TSC niche” [44]. This niche
resembles a “breeding chamber” stocked with cells, which
have specialized in providing factors that prevent differen-
tiation and thus maintain the stemness of the TSC and
ultimately the colony’s survival [44]. Like in supercolonies
of ants, such as the odorous house ant Tapinoma sessile
[45] that split and reunite again also solid tumors are
enriched by recirculating TSCs through cancer self-seeding
[46]. An overview of the functional relationships of solid
neoplasms and superorganisms is given in Table 1.
Evolution of division of labor
Queens that could produce progeny with traits of paren-
tal care uncoupled from reproduction [47-49] managed
to propagate their genes better than those who could
not. A similar principle might also apply to other biolo-
gical entities exposed to similar selection pressures. In
social insects, the evolution of highly cooperative socie-
ties from solitary insects presumably needed millions of
years due to relatively long generation time of indivi-
duals and the relatively low rate of genetic variation. In
contrast, due to inactivation of pro-apoptotic factors
and DNA-repair mechanisms, most cancer cells suffer
from great genomic instability, which dramatically accel-
erates the evolution of neoplasias [32,34,37,50,51]. How-
ever, most cancer cells (>99.8%) are believed to acquire
disadvantageous features and to go extinct before estab-
lishing a tumor [24,32,52].
Given that tumorigenesis requires acquisition of multi-
ple mutations during a period of many years, stem cells
are - due to their long life span - reasonable candidates
for the accumulation of mutations ultimately resulting
in malignant transformation [32,53]. In addition to their
long life span, stem cells are able to generate full
lineages of differentiated cells, thereby perpetuating
mutations through uncontrolled clonal expansion
[32,37]. Multiple studies suggest that neoplasias origi-
nate from stem cells or cells that have gained stem cell
properties [25,32,54-56]. These tumorigenic cells, the
TSCs, are believed to be the driving force in tumor pro-
gression and a possible cause of tumor heterogeneity
[25,52]. During tumorigenesis some TSCs will gain posi-
tive features by mutation, survive, and propagate this
survival benefit to their progeny [24,25,37]. Yet, it s still
unclear why a TSC gives rise to differentiated daughter
cells, which have lost the ability of unlimited self-
renewal, and what kind of selective advantage this pro-
cess could have for the overall fitness of the tumor (for
review see [54] and references therein)?
Our model of solid tumors as superorganisms would
predict that in the very early phase of a solid tumor all
TSCs, albeit rare, would compete with their own progeny
for limited space and resources [24,34,52,57,58] unless
they manage to propagate traits of “parental care” and
cooperation to their offspring. Hence, initially a TSC may
need to compete with both: other TSCs and their
progeny and with its own offspring [24,33,34,52,57-59].
Table 1 functional relationships of superorganisms and solid neoplasms
Feature Superorganism Solid neoplasm
Sociobiological aspect Sociogenesis: growth and development of the colony Tumorigenesis: growth and development
of the tumor
Reproduction and self-renewal Queen (foundress) Tumor stem cells (TSCs)
Specialization for housekeeping
work
Worker caste (non-reproductive) Non-TSC (progeny = limited proliferation,
no tumor-initiation ability)
Protection from intruders Specialized defensive castes: alarm-defense communication, colony
recognition labels, camouflage and pheromone repellants
Secretion of anergy inducing cytokines
Downregulation of major
histocompatibility complexes (MHC)
Communication and interaction
among colony members
Pheromones, visual, auditory and haptic signals Paracrine hormone and cytokine
communication, direct cell-cell contact
Shelter and microclimate
control
Nest construction Induction of fibrosis
High intratumoral hydrostatic pressure
Habitat Ecosystem Organism
Cargo flux and circulatory
system
“Ant highways” (Neo)-angiogenesis
Angiogenic mimicry
Driving force for adaptation Natural selection Intercellular competition and selection,
immunoediting and genetic instability
Multi-colony-formation (inter-
group-competition)
Supercolonies
Budding and fusion of individual colonies with the supercolony
Symmetric cell division and formation of
new TSCs
Cancer self-seeding
Colony founding Queen flight Metastasis of TSCs
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Its great genetic instability is even likely to aggravate the
TSC’s struggle within intercellular competition, because
it may lead to acquisition of negative traits that under-
mine cooperation and thus are deleterious for the TSC
itself. Put in another way, a nascent tumor is exposed to
several selective pressures arising from inter-cellular
competition for limited space and nutrients and from the
host’s immune system as discussed later.
However, some TSCs may by chance manage to pro-
pagate epigenetically and/or genetically fixed traits [60]
of parental care and cooperation to its non-TSC off-
spring during asymmetric cell division. In this scenario,
the scale of intercellular cooperation would be larger
than the scale of intercellular competition. Accordingly,
TSCs that produce non-TSCs with a high degree of
cooperation should disperse and outcompete those lack-
ing a similar degree of cooperation, because the non-
TSCs carrying traits of parental care and cooperation
would now alter the environment in a way that makes
TSC survival and proliferation more likely, that is, they
set-up a well-organized novel tissue with its own inter-
nal homeostasis - a so-called TSC niche.
This niche would enhance the overall fitness of the
TSC and its progeny for inter-group competition
between different TSCs and their progeny. This implies
that there might exist mechanisms by which clonemates
of one TSC might recognize each other while cooperat-
ing. Hence, tumor progression in its microenvironment
is, what we believe, similar to the evolution of a super-
organism through natural selection in its ecosystem.
Most advanced neoplasms are likely to consist of mul-
tiple TSCs and their corresponding non-TSC offspring
[32,37]. These multiple TSCs are thought to be derived
form one common ancestral TSC (referred to as the
“one renegade cell”) [23], but may, after some time of
tumor progression, differ from each other due to epige-
netic and/or genetic mutations acquired by each TSC
individually [32,37]. In analogy, a small number of so-
called “unicolonial” social insects more or less comple-
tely lack colony borders. This greatly reduces inter-col-
ony competition and increases the ecological success of
such invasive species. It is debated whether unicolonial-
ity is a consequence of the unhindered growth of found-
ing colony after a single introduction event associated
with the depletion of diversity in genetic odor cues dur-
ing the invasion of new habitats [61] or an adaptive
response to the new environment [62] (Figure 1).
Hence, according to our functional compartment
model a TSC needs to propagate traits of division of
labor that are exclusively activated in its progeny,
because a TSC cannot functionally differentiate and
maintain at the same time its stem cell character that is
by definition an undifferentiated state. Vice versa, the
functional differentiation of the TSC’s progeny is
acquired at the expense of stemness and thus reproductive
capacity. In this scenario both the TSC and its progeny
would die out if they were not to act as a cooperative unit.
Viewed from an inclusive fitness perspective, the tumor as
a whole enhances its reproductive fitness by cooperation
and division of labor - that is the TSC subordinates its
non-reproductive descendants by epigenetic programs that
commit them to functional differentiation for altruistic
behavior. Like social insect workers, non-reproductive
cells increase their own fitness indirectly by “helping” the
TSC to spread copies of their genes identical by descent
via metastazation. Therefore, an important aim of research
on tumor heterogeneity may be to decipher the algorithms
that direct tumor self-construction by division of labor as
allegorized by functional compartmentalization of
superorganisms.
Colony members to some extent can switch tasks
according to the context in a self-organizing manner
[6,19]. This results in a highly adaptive functional onto-
geny of temporal division of labor and task allocation
that is maintained by haptic, pheromonal and chemotac-
tic signals [5,6,63], and which is similarly present in
neoplasms (e.g. as a complex bouquet of auto- and para-
crine feedback loops) [22]. For instance, some tumor
cells within breast cancer are known to stimulate their
clonemates via secreted factors such as lysophosphatidic
acid (LPA) [64] and epidermal growth factor (EGF) [65].
The response upon these factors in turn depends on the
expression profile of cognate receptor(s) on the surface
of the receiving tumor cell(s). Hence, albeit these ligands
might be ubiquitously present throughout the entire
tumor mass, only certain subsets of tumor cells might
react on them as a functional compartment because
they are epigenetically or genetically programmed to
express the cognate receptor(s).
Moreover, the propensity of taking over certain tasks
may correlate with the age of an individual. As colony
members grow older, they proceed through a loosely
defined series of labor roles (age-polyethism): those
entail nursing of the queen and brood at first (close vici-
nity of young individuals to the reproductive), then
housekeeping labor (nutrition, detoxification) elsewhere
in the colony, and finally foraging outside [9,15,19].
Though genetic influences on caste differentiation [66]
and division of labor have been documented [67-70],
caste differences are usually based on epigenetic differ-
ences. Thus, as first suggested by Darwin, genes do not
determine castes but caste plasticity responding to
environmental conditions [71].
This suggests that genetic or epigenetic variations
determine the sensitivity of an individual to specific
proximate factors of the environment, which thereby
guide the commitment to one or another caste [72],
which is likely also true for tumors [73,74] (Figure 2).
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Below we will highlight some specific analogies
between tumors and superorganisms focusing mainly on
how TSCs and their progeny benefit from division of
labor:
Angiogenesis
Social insect species with populous societies have
evolved sophisticated strategies of shelter and alimenta-
tion. Workers construct tunnels and trail systems that
guarantee constant oxygen and food supply to the col-
ony’s breeding core [5,6,63]. This is akin to specialized
tumor cells that attract complex vascular networks and
simultaneously induce sheltering fibrosis - a process
termed heterotypic tumor/stroma interaction [29]. In
addition, growing evidence suggests that within some
cancers neoplastic cells differentiate into vessel-like
“parenchyma”. Angiogenic mimicry complements
tumor-induced angiogenesis as a form of tumor meta-
plasia [29,75], a process that also applies to other forms
of trans-differentiation (e.g. hormone production), which
may present clinically as a paraneoplastic syndrome [76].
Although the degree to which cancer cells resemble
endothelial cells is debatable, there is agreement that
cancer cells can directly line the lumen of functional
tumor blood vessels [77]. These cells, like the foragers
in ant colonies, do not reproduce, but instead enable
tumor growth indirectly by attraction of heterotypic tis-
sues through chemotactic substances (e.g. VEGF) [29],
as ants attract and recruit nestmates and even prey by
odor trails and pheromones [5,6].
Moving out
Sporadically, TSCs interrupt their notorious asymmetric
cell cycling and produce other TSCs through symmetric
cell division [78]. These new TSCs may differ from their
differentiated clonemates not only in pluripotency, but
also in possibly acquired traits for metastasis [79]. In ant
colonies, metastasis is mirrored by young queens travel-
ing to distant places within the ecosystem in search for
a place suitable for establishing new breeding chambers
[5,6]. Likewise, novel pluripotent TSCs disperse to new
microenvironments within the body that harbor a “nat-
ural” proper niche (soil) [80].
Under natural conditions, solitary colony founding is
by far the most dangerous phase in the life history of an
individual queen, and a large percentage of young
Figure 1 Selection pressure and evolution of social organisms: A) Each individual cell or organism is embedded in an environment, and
both impose constant selection pressure in terms of harmful effects on each other (arrows; the width of the arrows corresponds to the strength
of the executed selection pressure). B) Non-social individuals of the same generation compete with each other for resources. For reasons of
clarity the selection pressure of the environment is not depicted albeit constantly present. C) Non-social individuals of proximate generations
(parental, blue; F1, orange) also compete all with each other (inter-individual selection). D) Social individuals can reduce the inter-individual
selection pressure by propagating “altruistic genes”, and hence can cope better with the environment (see arrows; the circle resembles the
colony). E) Colonies of social individuals may drive non-social individuals to go extinct, although they compete with each other (inter-group
selection). In social insects, genes engendering cooperation, and specifically the developmental plasticity needed for an efficient division of labor,
will be selected because cooperative groups can either outcompete less cooperative groups and/or cooperation allows persistence in otherwise
inhospitable environments. F) In addition, individuals and their colonies may cooperate to reduce inter-colony selection pressure, as seen in
supercolonies of social insects and in solid tumors composed of thousands of tumor stem cells (TSCs) and their inter-cooperating progeny
(depicted as overlapping circles).
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queens fall victim to predators or parasites. Social
insects therefore usually delay the production of sexuals
until they have reached a critical worker number at
which the efficient production of large numbers of sex-
ual offspring has become feasible [5,8]. In analogy,
metastasis is often observed for the first time at late
tumor stages, which have already reached a considerable
size [81]. Our functional compartment model of a solid
tumor as a superorganism suggests that very small
tumors simply cannot afford the loss of cells through
precocious metastasis, since they could not support the
assembly of the early tumor niche, which would be very
disadvantageous for the survival of the young primary
colony.
Although metastasis will be lethal for most of the
tumor cells, a very few will succeed in founding new
colonies enabled by either acquired beneficial traits on
their journey or pre-existing favorable factors of their
own and/or the microenvironment [80]. Upon arrival,
TSCs will start to reactivate intrinsic programs of asym-
metric cell division to found a new colony that is a
metastasis [82], while losing migratory activity like ant
queens cast off their wings. In epithelial tumors this
“spread and seed” is performed by the embryonic trait
of epithelial-mesenchymal-transition and its reversal in
mesenchymal-epithelial-transition [79]. During metasta-
sis most metastasizing cells encounter new and possibly
hostile environments (e.g. surrounding tissue, blood or
lymphatic fluid), which may select for certain traits of
the cells that allow survival in and colonization of other
organs. Moreover, cells within already established
metastases continue to underlie spontaneous (epi-)
genetic mutations. Hence, metastasized cells often differ
markedly from their parental primary tumor [83].
Interestingly, cancer cells may cooperate to change the
microenvironment and ultimately found a new colony
[84]. In analogy, in honeybees and many ant species new
colonies are founded cooperatively by queens and work-
ers by budding or fragmentation of the maternal colony
[5,6,15]. Likely, TSCs also sporadically metastasize jointly
with other non-reproductive cells (workers) in a coordi-
nated fashion [84]. These TSC guardians may help to
establish an early TSC niche at the distant and possibly
hostile destination. Of note, this collective behavior of
invading and metastasizing cancer cell populations has
been recently also allegorized to swarm-like behavior of
social insects [57], which may be the result of very similar
coordinated processes of decision-making. In both sys-
tems only a very small proportion of actively invasive
individuals - that is the proportion of “decision-makers” -
is needed to cause a transition to collective and cohesive
motion of a large body of followers [57,85]. Hence, iden-
tifying and targeting the functional compartment of deci-
sion-makers inducing metastasis in cancer may have
profound clinical implications.
Surveillance and immunoediting
Superorganisms developed sophisticated mechanisms to
adapt and modify their environment and to cope with
rivals. Several ant species feign death or camouflage
themselves to confuse and repel predators. Others vio-
lently defend their territories in lethal battles, engage in
elaborated attack maneuvers and/or build specialized
nest constructions hampering intruders [5,6,15]. In ana-
logy, also a malignant tumor has to evade from control
mechanisms of the hosting organism in order to convey
its parasitic growth. Consistently, there is broad evidence
that tumors hijack features of immune cells, which were
intended to attack the tumor, for their own purposes. For
instance, some cancer cells specialize in recruiting
immune cells like macrophages by secretion of platelet
derived growth factor (PDGF), which in turn stimulates
angiogenesis, fibrosis and ultimately metastasis by secre-
tion of transforming growth factor beta (TGF-beta), EGF
and receptor activator of NF-kappa-B ligand (RANKL)
(for review see [22] and references therein).
These immuno-evasive features are thought to evolve
during tumor evolution through the interplay of tumor
cells and the innate and adaptive immunity:
Paul Ehrlich first proposed that transformed cells arise
continuously within our bodies and that the immune
system eradicates them before they may form a clinically
Figure 2 Task switching and functional plasticity (adapted
from [6]): Part of the Darwinian success of superorganisms is the
ability of the workers to switch tasks quickly and reliably. This can
be understood as an issue of labor optimization: A) A non-social
organism has no choice when addressing a task but to perform it
as an unbroken series of steps. B) A colony can perform many such
tasks simultaneously in parallel series. C) The whole process
accelerates if the workers switch opportunistically from task to task
to perform whatever task is closest in a series-parallel process, which
is observed in some social insects. The efficacy of the system
increases if groups of workers are specialized in size, anatomical
proportions (allometry) and physiological competence (metabolic
division of labor) to perform certain roles. This kind of task
partitioning evidently decreases cost per unit yield in time and
energy.
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apparent tumor [86]. Subsequently, experimental evi-
dence by tumor transplantation models hinted to the
existence of tumor-associated antigens and promoted
the concept of immune surveillance [87]. Now it is
accepted that tumor infiltrating lymphocytes (TILs) can
attack and eradicate tumor cells. Accordingly, tumors
must evolve mechanisms to escape immune control in a
process called immunoediting, which consists of three
phases [28]:
(1) Elimination: solid tumor of more than 2-3 mm
require robust blood supply and stromal remodeling,
which in turn induces subtle inflammation. The trans-
formed cells can be recognized by recruited TILs that
initiate a specific immune response [28].
(2) Equilibrium: The continuous sculpting of tumor
cells selects immuno-resistant variants due to reduced
immunogenicity (immune selection), which explains the
apparent paradox of clinical tumor-formation in other-
wise immunocompetent individuals [28].
(3) Escape: diverse tumor-derived factors including
endothelial differentiation-related factor 1 (EDF1), VEGF,
interleukin 10 (IL-10) and TGF-beta induce complex
local and regional immunosuppressive networks.
Although deposited at the primary site, these soluble fac-
tors extend immunosuppressive effects into local lymph
nodes and the spleen, thereby facilitating invasion and
metastasis [88,89]. According to our model of division of
labor within a solid tumor, it is likely that those factors
may only be secreted by specialized non-TSCs.
Although many cancers express specific antigens,
immune surveillance appears inefficient. As some social
insects reduce their visibility by elaborate camouflage
techniques [6], tumor cells may elude immune control
by downregulation of their major histocompatibility
complexes (MHC) [90,91]. Likewise, the tumor stroma
also has immuno-protective functions [92]: the tumor
stroma (non-tumor cells and extracellular matrix) binds
and obscures tumor antigens and thus competes with
antigen-presenting cells for the antigen and additionally
increases the intratumoral interstitial fluid pressure pre-
venting immigration of immune effectors [93]. Hence,
tumor cells that specialize in inducing fibrosis may con-
tribute to the overall fitness of the tumor.
Targeting algorithms of division of labor that
direct self-construction of solid tumors
Though the details of division of labor and caste differ-
entiation in insect societies are not completely under-
stood, the processes involved have been described as
social algorithms, i.e., epigenetic programs that can be
regarded as an operating manual by which the colony
assembles itself. Each step of the program is determined
by decision rules that allow an individual to proceed on a
defined pathway from one to the next decision point until
the end of the sequence is reached. A complete sequence
of such binary decisions is called an algorithm [6]. In ana-
logy to social insects, an inherent epigenetic program may
guide a tumor cell along a sequence of gradual differentia-
tion towards a specific function that is relevant for the
whole tumor or it may cause changes in the cell’s behavior
within its functional repertoire. Conditioned by the
ongoing and simultaneous decisions of all cells, the tumor
as a whole creates emergent patterns of adaptive responses
to environmental conditions such as therapy and hypoxia
[22,24,94]. The epigenetic program in each cell thereby
defines how and upon which stimuli it will react.
According to our functional compartment model of
solid tumors as superorganisms we can identify at least
two major decision points of a TSC and its non-TSC
derivatives: first the TSC has to decide, whether it will
divide symmetrically and thus duplicate or divide asym-
metrically and hence give rise to a more differentiated
non-TSC that may help to establish a TSC niche.
Within the second major step, a non-TSC has to
decide whether it will divide as a transitory amplifying
cell for the expense of delayed differentiation or whether
it differentiates early to gain special functions such
as attraction of blood vessels or induction of fibrosis.
Of note, functional differentiation is not necessarily
associated with morphological changes. Hence, tumor
heterogeneity may be achieved by either functional and/
or phenotypical differentiation [25] (Figure 3).
In analogy to a member of a certain caste within a
superorganism, these algorithmic cellular fate decisions
may be promoted by the cell’s inherent sensitivity to speci-
fic inductive factors of the environment, e.g. the sensitivity
to hypoxia, cytokines or other tumor cells. This sensitivity,
which is private to the non-TSC, might be the result of an
epigenetic program inherited from the cell’s ancestral TSC
at the time of asymmetric cell division.
Technical approaches and perspectives
The analysis of plasticity of functional labor roles as epi-
genetic (and in the case of solid tumors also genetic)
adaptations remains one of the outstanding challenges
of socio- as well as tumor biology. But how might pat-
terns of plasticity be conceptualized to advance the
understanding of division of labor?
The advances in technology through the 1980s and
1990s allowed for more efficient separation of cells
based on cell marker phenotypes, leading to the identifi-
cation of normal hematopoietic stem cells in 1988 [95].
However, since then the major obstacles to identify, pur-
ify and to distinguish TSC from their differentiated deri-
vatives mostly arise from the lack of robust markers
[25]. Using resources such as array comparative genomic
hybridization, expression sequence tags and microarrays
[96-98], researchers may possibly identify novel factors
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that induce functional compartmentalization of indivi-
dual tumor cells. The genomics era will succeed to scru-
tinize genetically complex patterns of functional traits
controlled by multiple genes [99].
If we identified caste specific and thus functionally
related cell surface markers, we would be able to sort
and expand those cells in vitro and subject them to
various functional assays such as drug-resistance screen-
ings [25]. Moreover, those markers could be used to
label distinct functional compartments in tumor tissue
sections to enable microarray-based analysis of gene
expression signatures in microdissected cells [100] of
clinical specimens of the patients’ tumors. These data
could be further analyzed in silico to characterize gene
expression patterns associated with drug response and
prognosis. Functional characterization of those expres-
sion patterns would possibly distill bona fide targets for
pharmaceutical high-through-put screenings such as the
surface-plasmon-resonance technique for small molecule
inhibitors, which has already lead to the identification of
promising anti-cancer agents [101].
Conclusions: lessons learned from superorganisms
Clinically, traits of functional compartmentalization and
stemness correlate with metastatic disease and thus
poor prognosis [102,103]. For decades, classical che-
motherapy was directed against the highly proliferating
progeny of TSCs. Slowly proliferating TSCs are, how-
ever, rarely affected and are nowadays accepted as the
major cause of relapse [39,104].
Thinking of solid neoplasms as superorganisms with
complex compartments and functions clarifies that a che-
motherapeutic strategy addressing only the proliferating
caste is not likely to succeed in eradicating all tumor cells
in all compartments, as well as those on the move (G0
phase during metastasis). To kill an ant colony effectively
it is not enough to simply kill the workers but the repro-
ductive queen needs to be destroyed. Modern control pro-
ducts are designed to exactly do this [6]. Likewise, cancer
therapies are most likely best targeted at the level of TSCs.
We think that beyond the targeted therapy of TSCs,
though, modern anti-cancer therapies also need to include
drugs specifically directed against non-TSCs that have
functional relevance for the whole tumor (e.g. cells that
promote angiogenesis/vasculogenic mimicry, fibrosis and
immune escape). Thus, one important goal of research on
tumor-heterogeneity is to understand the underlying algo-
rithms and mechanisms of tumor sub-specialization. This
will enable the development of novel concepts of targeted
therapy, which will specifically attack each cohort of sub-
specialized tumor cells (Figure 3).
Only if we succeed in identifying the underlying algo-
rithms of the superorganism “solid tumor”, we can ela-
borate complex, multilayered, and personalized therapy
strategies, which can overcome the heterogeneous func-
tional compartments and thus the tumor itself.
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